Article
Molecular pharmacodynamics of amoxicillin-clavulanic acid against Escherichia coli
2025-12-10
Abstract excerpt
<title>Abstract</title> <p> Amoxicillin-clavulanic acid (AMX-CLV) is a widely used oral β-lactam/β-lactamase inhibitor combination against <italic>Escherichia coli</italic> . Clinical success is largely confined to urinary tract infections. The mechanistic basis for this site-specific efficacy remains unclear. Using a hollow-fibre infection model to replicate human plasma and urinary pharmacokinetics, we show...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 54cb3b64-8006-5f8b-afec-819f870e4217
- DOI
- 10.21203/rs.3.rs-8148425/v1
